プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. GOURANGA S.に依頼

India

PhD Cancer Biologist | Scientific Manuscript Editor | MSCA Seal of Excellence | 7+ Years in Molecular Oncology

プロフィール概要

I am a PhD molecular cancer biologist with 7+ years of post-graduate research experience and a proven publication record in high-impact oncology and cell biology journals. As a first author, I have published in Oncogene, BBA Reviews on Cancer, BBA Molecular Cell Research, and Molecular Cell — journals that demand rigorous mechanistic clarity, precise data narration, and compelling scientific storytelling. I have also co-authored research in Chemico-Biological Interactions, International Journal of Pharmaceutics, and Cell Cycle, and contributed three book chapters to Springer, spanning encyclopedic signalling biology to post-COVID global health analysis. This breadth reflects my ability to adapt my scientific voice to diverse audiences, from specialist reviewers to interdisciplinary readers. I specialise in scientific manuscript editing, grant proposal writing, and pre-submission peer review for researchers in cancer biology, ubiquitin–proteasome systems (UPS), deubiquitinase (DUB) biology, DNA damage response, and proteomics. Unlike general editing services, I bring deep domain expertise — I understand the science behind your data, which means I improve not just your grammar and syntax, but your logical flow, mechanistic reasoning, figure–text alignment, and reviewer readiness. I have mentored junior PhD students through their first manuscript submissions and trained researchers in LC-MS/MS proteomics data interpretation and scientific writing standards at the Regional Centre for Biotechnology (RCB). I hold the MSCA 2025 Seal of Excellence (88.2%) from the European Commission, awarded for a postdoctoral fellowship proposal that exceeded the EU quality threshold. This distinction reflects my ability to craft competitive, high-stakes scientific narratives under strict word limits and evaluation criteria. I work extensively with ESL authors, junior faculty building their first lab papers, and postdocs preparing fellowship applications for MSCA, NIH, Wellcome Trust, and ICMR. Whether you need a polished manuscript for Nature, Cell, or Science-family journals, a strategic reviewer response, or a winning grant proposal, I deliver publication-ready work with fast turnaround. Available for one-time projects or ongoing retainer arrangements.

専門分野

• ☆ Materials Science & Engineering
• ☆ Nanotechnology
• ☆ Molecular Biology
• ☆ Omics
• ☆ Proteomics
• ☆ Metabolomics
• ☆ Molecular Cloning
• ☆ DNA Sequencing
• ☆ Breast Cancer
• ☆ Men's Health
• ☆ Prostate Cancer
• ☆ Gastroenterology & Hepatology
• ☆ Colorectal Cancer
• ☆ Cancer Biology
• ☆ Carcinogenesis

サービス

• Writing
• Research

Writing Medical Writing, Technical Writing

Research Gap Analysis, Scientific and Technical Research, Systematic Literature Review

職務経験

Doctoral Fellow

Indian Institute of Chemical Biology

- 現在

Technical Service Provider at the i3C BRIC- Ph.D. Programme in Biosciences

Regional Centre for Biotechnology

2月 2025 - 現在

学歴

PhD in Biotechnology

Calcutta University

6月 2017 - 11月 2023

認定資格

• PhD in Biotechnology

  Calcutta university

  11月 2023 - 現在

出版物

JOURNAL ARTICLE

Roy, S., Saha, G., & Ghosh, M. K. (2025). UPS and Kinases-Gatekeepers of the G1/S Transition. BioFactors (Oxford, England), 51(3), e70020. https://doi.org/10.1002/biof.70020 .

Saha, Gouranga, and Mrinal K Ghosh. “The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer.” Biochimica et biophysica acta. Molecular cell research, vol. 1872,3 119908. 27 Jan. 2025, doi:10.1016/j.bbamcr.2025.119908 .

Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023). USP7 - a crucial regulator of cancer hallmarks. Biochimica et biophysica acta. Reviews on cancer, 188903. Advance online publication. https://doi.org/10.1016/j.bbcan.2023.188903 .

Mukherjee, S., Saha, G., Roy, N. S., Naiya, G., Ghosh, M. K., & Roy, S. (2023). A small HDM2 antagonist peptide and a USP7 inhibitor synergistically inhibit the p53-HDM2-USP7 circuit. Chemical biology & drug design, 10.1111/cbdd.14255. Advance online publication. https://doi.org/10.1111/cbdd.14255 .

Saha G, Sarkar S, Mohanta PS, Kumar K, Chakrabarti S, Basu M, Ghosh MK (2022). USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma . Oncogene.

PREPRINT

Gouranga Saha, Sibani Sarkar, Sunny Kumar, Malini Basu, Mrinal K Ghosh(2023). PLGA-based dual-loaded nanoformulation of DIM and TMZ - An advanced clinical strategy for brain cancer treatment in a combinatorial approach . Cold Spring Harbor Laboratory

BOOK CHAPTER

Gouranga Saha, Bhaskar Basu, Seemana Bhattacharya, Mrinal K. Ghosh(2018). USP7 (Ubiquitin-Specific Protease 7) . Encyclopedia of Signaling Molecules. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5849--5854. Springer International Publishing